<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03195504</url>
  </required_header>
  <id_info>
    <org_study_id>16-6264.0</org_study_id>
    <nct_id>NCT03195504</nct_id>
  </id_info>
  <brief_title>High-flow Nasal Oxygenation in Obese Patients During Apnea</brief_title>
  <official_title>Effectiveness of Apneic Oxygenation Using High-flow Nasal Cannula in Morbidly Obese Patients Undergoing General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Before going off to sleep patients are given oxygen to saturate blood with oxygen to extend
      time before a decrease in the level of oxygen in the blood occurs. During this period, obese
      patients have a faster decrease in the level of oxygen in their blood. This study uses a
      device called &quot;high-flow nasal cannula&quot; (HFNC), which delivers humidified high-flow oxygen
      through 2 small plastic tubes placed just inside nostrils. In the intensive care unit
      settings this device has been used extensively and has become a standard practice. Purpose of
      this study is to determine whether these high-flow nasal cannula increase the time safely
      when going to sleep during elective surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 10, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Consented patients will be randomly assigned either to the interventional group (High Flow Nasal Cannula- HFNC) or to the control group (CON). The Group HFNC will be preoxygenated using HFNC and the Group CON will receive standard preoxygenation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of safe apnea time</measure>
    <time_frame>Maximum up to 6 minutes</time_frame>
    <description>Safe apnea time, defined by time to desaturation (SpO2 &gt; 95%) or apnea maximum up to 6 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Highest EtCO2</measure>
    <time_frame>Every minute up to 5 minutes on commencing ventilation</time_frame>
    <description>Highest EtCO2 on commencing ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lowest SpO2</measure>
    <time_frame>Every minute up to 5 minutes after intubation</time_frame>
    <description>Lowest SpO2 during intubation procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to regain baseline SpO2</measure>
    <time_frame>Up to 5 minutes after intubation</time_frame>
    <description>Time to regain baseline SpO2 after intubation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Apneic Oxygenation</condition>
  <condition>High-flow Nasal Cannulae</condition>
  <condition>Bariatric Surgery</condition>
  <condition>Anesthesia Induction</condition>
  <arm_group>
    <arm_group_label>HFNC (High Flow Nasal Cannulae)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Flow Nasal Cannulae providing humidified, high-flow oxygen during induction of anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CON (control)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard flow oxygen during induction of anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFNC</intervention_name>
    <description>High flow nasal oxygen (60 l) under GA</description>
    <arm_group_label>HFNC (High Flow Nasal Cannulae)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CON (control)</intervention_name>
    <description>Standard oxygen (10-15 l) under GA</description>
    <arm_group_label>CON (control)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than18 years old

          -  ASA status I-III

          -  Elective surgery performed under general anesthesia requiring endotracheal intubation

          -  BMI more than 40 kg/m2

        Exclusion Criteria:

          -  Chronic respiratory disease

          -  SpO2 &lt;98% after supplementing oxygen

          -  Previous or anticipated difficult intubation

          -  Uncontrolled hypertension

          -  Ischemic heart disease

          -  Congestive heart failure

          -  Increased intracranial pressure

          -  Uncontrolled GERD

          -  Known allergy or contraindication to anesthesia drugs

          -  Nasal blockade contraindicating the use of HFNC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>David T Wong, MD</last_name>
    <phone>+1-416 603-5118</phone>
    <email>david.wong@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kawal P Singh, CRC</last_name>
    <phone>+1-416 603-5118</phone>
    <phone_ext>3959</phone_ext>
    <email>kpsingh@uhnresearch.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David T Wong, MD</last_name>
      <phone>+1-416-603-5118</phone>
      <phone_ext>5496</phone_ext>
      <email>david.wong@uhn.ca</email>
    </contact>
    <contact_backup>
      <last_name>Kawal P Singh, CRC</last_name>
      <phone>+1-416-603-5118</phone>
      <phone_ext>3959</phone_ext>
      <email>kpsingh@uhnresearch.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2017</study_first_submitted>
  <study_first_submitted_qc>June 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2017</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>David Wong</investigator_full_name>
    <investigator_title>Professor Anesthesia (MD)</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

